The Non-Small Cell Lung Cancer Market is Estimated To Witness High Growth Owing To Advances in Therapeutics
The Non-Small Cell Lung Cancer Market is estimated to be valued at US$ 27252.31 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancers. It usually develops in the outer parts of the lungs. The...
0 Commentaires 0 Parts 1101 Vue 0 Aperçu
Commandité